Vascular smooth muscle Jak2 deletion prevents angiotensin II-mediated neointima formation following injury in mice

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 6, 2011, Pages 1026-1034

  Kirabo, Annet ^a   Oh, S Paul ^a   Kasahara, Hideko ^a   Wagner, Kay Uwe ^b   Sayeski, Peter P ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Angiotensin II; Jak2; Neointima; Vascular injury; Vascular smooth muscle cells

Indexed keywords

ALPHA ACTIN; ANGIOTENSIN II; JANUS KINASE 2; STAT5 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD VESSEL INJURY; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE DELETION; GENOTYPE; MALE; MORPHOMETRICS; MOUSE; NEOINTIMA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ACTINS; ANGIOTENSIN II; ANIMALS; APOPTOSIS; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DISEASE MODELS, ANIMAL; FEMALE; FIBROSIS; JANUS KINASE 2; MALE; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; NEOINTIMA; PHOSPHORYLATION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; VASCULAR SYSTEM INJURIES;

MUS;

EID: 79955671191     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.03.005     Document Type: Article

References (44)

1. Owens G.K., Vernon S.M., Madsen C.S. Molecular regulation of smooth muscle cell differentiation. J Hypertens Suppl 1996 Dec, 14(5):S55-S64.
2. Owens G.K., Kumar M.S., Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004 Jul, 84(3):767-801.
3. Sobue K., Hayashi K., Nishida W. Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation. Mol Cell Biochem 1999 Jan, 190(1-2):105-118.
4. Parganas E., Wang D., Stravopodis D., Topham D.J., Marine J.C., Teglund S., et al. Jak2 is essential for signaling through a variety of cytokine receptors. Cell 1998 May 1, 93(3):385-395.
5. Neubauer H., Cumano A., Muller M., Wu H., Huffstadt U., Pfeffer K. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell 1998 May 1, 93(3):397-409.
6. Delhommeau F., Pisani D.F., James C., Casadevall N., Constantinescu S., Vainchenker W. Oncogenic mechanisms in myeloproliferative disorders. Cell Mol Life Sci 2006 Dec, 63(24):2939-2953.
7. Kirabo A., Sayeski P.P. Jak2 tyrosine kinase: a potential therapeutic target for AT1 receptor mediated cardiovascular disease. Pharmaceuticals 2010, 3(11):3478-3493. 9 November 2010.
8. Geisterfer A.A., Peach M.J., Owens G.K. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 1988 Apr, 62(4):749-756.
9. Berk B.C., Vekshtein V., Gordon H.M., Tsuda T. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 1989 Apr, 13(4):305-314.
10. Daemen M.J., Lombardi D.M., Bosman F.T., Schwartz S.M. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991 Feb, 68(2):450-456.
11. Su E.J., Lombardi D.M., Wiener J., Daemen M.J., Reidy M.A., Schwartz S.M. Mitogenic effect of angiotensin II on rat carotid arteries and type II or III mesenteric microvessels but not type I mesenteric microvessels is mediated by endogenous basic fibroblast growth factor. Circ Res 1998 Feb 23, 82(3):321-327.
12. Xi X.P., Graf K., Goetze S., Fleck E., Hsueh W.A., Law R.E. Central role of the MAPK pathway in Ang II-mediated DNA synthesis and migration in rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999 Jan, 19(1):73-82.
13. Seki Y., Kai H., Shibata R., Nagata T., Yasukawa H., Yoshimura A., et al. Role of the JAK/STAT pathway in rat carotid artery remodeling after vascular injury. Circ Res 2000 Jul 7, 87(1):12-18.
14. Shibata R., Kai H., Seki Y., Kato S., Wada Y., Hanakawa Y., et al. Inhibition of STAT3 prevents neointima formation by inhibiting proliferation and promoting apoptosis of neointimal smooth muscle cells. Hum Gene Ther 2003 May 1, 14(7):601-610.
15. Meydan N., Grunberger T., Dadi H., Shahar M., Arpaia E., Lapidot Z., et al. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 1996 Feb 15, 379(6566):645-648.
16. Marrero M.B., Schieffer B., Paxton W.G., Heerdt L., Berk B.C., Delafontaine P., et al. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 1995 May 18, 375(6528):247-250.
17. Ihle J.N. STATs: signal transducers and activators of transcription. Cell 1996 Feb 9, 84(3):331-334.
18. Schieffer B., Bernstein K.E., Marrero M.B. The role of tyrosine phosphorylation in angiotensin II mediated intracellular signaling and cell growth. J Mol Med 1996 Feb, 74(2):85-91.
19. Krempler A., Qi Y., Triplett A.A., Zhu J., Rui H., Wagner K.U. Generation of a conditional knockout allele for the Janus kinase 2 (Jak2) gene in mice. Genesis 2004 Sep, 40(1):52-57.
20. Li L., Miano J.M., Mercer B., Olson E.N. Expression of the SM22alpha promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J Cell Biol 1996 Mar, 132(5):849-859.
21. Mao X., Fujiwara Y., Orkin S.H. Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice. Proc Natl Acad Sci USA 1999 Apr 27, 96(9):5037-5042.
22. Wang X., Xu L. An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research. Thromb Res 2005, 115(1-2):95-100.
23. Daugherty A., Manning M.W., Cassis L.A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000 Jun, 105(11):1605-1612.
24. Chen G., Wu J., Sun C., Qi M., Hang C., Gong Y., et al. Potential role of JAK2 in cerebral vasospasm after experimental subarachnoid hemorrhage. Brain Res 2008 Jun 12, 1214:136-144.
25. Sayeski P.P., Ali M.S., Harp J.B., Marrero M.B., Bernstein K.E. Phosphorylation of p130Cas by angiotensin II is dependent on c-Src, intracellular Ca2+, and protein kinase C. Circ Res 1998 Jun 29, 82(12):1279-1288.
26. Ray J.L., Leach R., Herbert J.M., Benson M. Isolation of vascular smooth muscle cells from a single murine aorta. Methods Cell Sci 2001, 23(4):185-188.
27. Denizot F., Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986 May 22, 89(2):271-277.
28. Schwartz S.M., Reidy M.A., O'Brien E.R. Assessment of factors important in atherosclerotic occlusion and restenosis. Thromb Haemost 1995 Jul, 74(1):541-551.
29. HajMohammadi S., Enjyoji K., Princivalle M., Christi P., Lech M., Beeler D., et al. Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis. J Clin Invest 2003 Apr, 111(7):989-999.
30. Schafer K., Muller K., Hecke A., Mounier E., Goebel J., Loskutoff D.J., et al. Enhanced thrombosis in atherosclerosis-prone mice is associated with increased arterial expression of plasminogen activator inhibitor-1. Arterioscler Thromb Vasc Biol 2003 Nov 1, 23(11):2097-2103.
31. Woollard K.J., Sturgeon S., Chin-Dusting J.P., Salem H.H., Jackson S.P. Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury. J Biol Chem 2009 May 8, 284(19):13110-13118.
32. Wakabayashi K., Suzuki H., Sato T., Iso Y., Katagiri T., Takeyama Y. Eplerenone suppresses neointimal formation after coronary stent implantation in swine. Int J Cardiol 2006 Feb 15, 107(2):260-266.
33. Shibata R., Kai H., Seki Y., Kato S., Morimatsu M., Kaibuchi K., et al. Role of Rho-associated kinase in neointima formation after vascular injury. Circulation 2001 Jan 16, 103(2):284-289.
34. Davis C., Fischer J., Ley K., Sarembock I.J. The role of inflammation in vascular injury and repair. J Thromb Haemost 2003 Aug, 1(8):1699-1709.
35. Laporte S., Escher E. Neointima formation after vascular injury is angiotensin II mediated. Biochem Biophys Res Commun 1992 Sep 30, 187(3):1510-1516.
36. Marrero M.B., Schieffer B., Li B., Sun J., Harp J.B., Ling B.N. Role of Janus kinase/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J Biol Chem 1997 Sep 26, 272(39):24684-24690.
37. Palmiter R.D., Wilkie T.M., Chen H.Y., Brinster R.L. Transmission distortion and mosaicism in an unusual transgenic mouse pedigree. Cell 1984 Apr, 36(4):869-877.
38. Wilkie T.M., Brinster R.L., Palmiter R.D. Germline and somatic mosaicism in transgenic mice. Dev Biol 1986 Nov, 118(1):9-18.
39. Long M.A., Rossi F.M. Silencing inhibits Cre-mediated recombination of the Z/AP and Z/EG reporters in adult cells. PLoS ONE 2009, 4(5):e5435.
40. Calero-Nieto F.J., Bert A.G., Cockerill P.N. Transcription-dependent silencing of inducible convergent transgenes in transgenic mice. Epigenetics Chromatin 2010 Jan 19, 3(1):3.
41. Grote K., Luchtefeld M., Schieffer B. JANUS under stress-role of JAK/STAT signaling pathway in vascular diseases. Vasc Pharmacol 2005 Nov, 43(5):357-363.
42. Guilluy C., Bregeon J., Toumaniantz G., Rolli-Derkinderen M., Retailleau K., Loufrani L., et al. The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure. Nat Med 2010 Feb, 16(2):183-190.
43. Lata K., Madiraju N., Levitt L. JAK2 mutations and coronary ischemia. N Engl J Med 2010 Jul 22, 363(4):396-397.
44. Wang H., Li Y., Liu H., Liu S., Liu Q., Wang X.M., et al. Peroxynitrite mediates glomerular lesion of diabetic rat via JAK/STAT signaling pathway. J Endocrinol Investig 2009 Nov, 32(10):844-851.